Table 4.

Analysis by Racial/Ethnic Groups in Federally Funded Clinical Trials

	General medicine		Oncology		Cardiovascular		Infectious disease		Obstetrics and gynecology		Total
Studies	2004	2009	2004	2009	2004	2009	2004	2009	2004	2009	2004	2009
Analysis by race/ethnicity provided or variable included in model	4 (9)a	5 (11)	1 (9)	4 (20)	0	2 (25)	0	0	1 (13)	1 (8)	6 (9)	12 (14)
Did not analyze by race/ethnicity but provided explanation	5 (11)	4 (9)	0	1 (5)	0	0	0	0	1 (13)	1 (8)	6 (9)	6 (7)
Did not include race/ethnicity in analysis or did not provide an explanation or both	36 (80)	35 (80)	10 (91)	15 (75)	3 (100)	6 (75)	2 (100)	2 (100)	6 (75)	10 (83)	57 (83)	68 (79)
Total	45 (100)	44 (100)	11 (100)	20 (100)	3 (100)	8 (100)	2 (100)	2 (100)	8 (100)	12 (100)	69 (100)	86 (100)

Percentages may not total to 100% because of rounding.

^an (%).